OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: AcuraStem Incorporated

2 Projects | 2 Researchers | $3,092,453 Invested

2022

AcuraStem Incorporated

Peter Sazani, PhD

Late-stage development of a PIKFYVE antisense oligonucleotide treatment for FTD

  • Funding Amount: $2,927,453
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Neuronal Degeneration
  • Status: Active

2020

AcuraStem Incorporated

Wen-Hsuan Chang, PhD

Development of a PIKFYVE antisense oligonucleotide (ASO) treatment for FTD

  • Funding Amount: $165,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Neuronal Degeneration
  • Status: Active